aluates Reports

$ 0.0

Automative

Paclitaxel- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Published Date: August 2025

Report Code: QYRE-Auto-37L8796

BUY CHAPTERS

Paclitaxel- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-37L8796

Report

August 2025

Pages:127

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

ScinoPharm

Samyang

Polymed

TAPI (Teva)

Fresenius Kabi

Huiang biopharma

Yunnan Hande

Hainan Yew Pharm

Jiangsu Yew Biotechnology

Southpharma

Novasep

Phyton

Paclitaxel- Market Size

The global market for Paclitaxel was estimated to be worth US$ 138 million in 2024 and is forecast to a readjusted size of US$ 237 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.

Paclitaxel- Market

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".

North America and China are the largest producer of Paclitaxel, with a market share about 35% separately. Phyton, ScinoPharm, Huiang biopharma, Southpharma and Novasep are the top 5 manufacturers of industry, and they had more than 60% combined market share.

This report aims to provide a comprehensive presentation of the global market for Paclitaxel, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Paclitaxel by region & country, by Type, and by Application.

The Paclitaxel market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paclitaxel.

Market Segmentation

Scope of Paclitaxel- Market Report

Report Metric	Details
Report Name	Paclitaxel- Market
Forecasted market size in 2031	US$ 237 million
CAGR	8.2%
Forecasted years	2025 - 2031
Segment by Type	Natural Paclitaxel API Semi-synthetic Paclitaxel API
Segment by Application	Ovarian Cancer Cervical Cancer Breast Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma, Southpharma, Yunnan Hande, Hainan Yew Pharm, Jiangsu Yew Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Paclitaxel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Paclitaxel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Paclitaxel in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Paclitaxel- Market size in 2031?

Ans: The Paclitaxel- Market size in 2031 will be US$ 237 million.

What is the Paclitaxel- Market share by region?

Ans: North America and China are the largest producer of Paclitaxel, with a market share about 35% separately.

What is the market share of major companies in Paclitaxel- Market?

Ans: Phyton, ScinoPharm, Huiang biopharma, Southpharma and Novasep are the top 5 manufacturers of industry, and they had more than 60% combined market share.

Who are the main players in the Paclitaxel- Market report?

Ans: The main players in the Paclitaxel- Market are Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma, Southpharma, Yunnan Hande, Hainan Yew Pharm, Jiangsu Yew Biotechnology

What are the Application segmentation covered in the Paclitaxel- Market report?

Ans: The Applications covered in the Paclitaxel- Market report are Ovarian Cancer, Cervical Cancer, Breast Cancer, Others

What are the Type segmentation covered in the Paclitaxel- Market report?

Ans: The Types covered in the Paclitaxel- Market report are Natural Paclitaxel API, Semi-synthetic Paclitaxel API

Recommended Reports

Cancer Therapeutics

Taxane Derivatives

Cancer Drug Indications

1 Market Overview

1.1 Paclitaxel Product Introduction

1.2 Global Paclitaxel Market Size Forecast

1.2.1 Global Paclitaxel Sales Value (2020-2031)

1.2.2 Global Paclitaxel Sales Volume (2020-2031)

1.2.3 Global Paclitaxel Sales Price (2020-2031)

1.3 Paclitaxel Market Trends & Drivers

1.3.1 Paclitaxel Industry Trends

1.3.2 Paclitaxel Market Drivers & Opportunity

1.3.3 Paclitaxel Market Challenges

1.3.4 Paclitaxel Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Paclitaxel Players Revenue Ranking (2024)

2.2 Global Paclitaxel Revenue by Company (2020-2025)

2.3 Global Paclitaxel Players Sales Volume Ranking (2024)

2.4 Global Paclitaxel Sales Volume by Company Players (2020-2025)

2.5 Global Paclitaxel Average Price by Company (2020-2025)

2.6 Key Manufacturers Paclitaxel Manufacturing Base and Headquarters

2.7 Key Manufacturers Paclitaxel Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Paclitaxel

2.9 Paclitaxel Market Competitive Analysis

2.9.1 Paclitaxel Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Paclitaxel Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Natural Paclitaxel API

3.1.2 Semi-synthetic Paclitaxel API

3.2 Global Paclitaxel Sales Value by Type

3.2.1 Global Paclitaxel Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Paclitaxel Sales Value, by Type (2020-2031)

3.2.3 Global Paclitaxel Sales Value, by Type (%) (2020-2031)

3.3 Global Paclitaxel Sales Volume by Type

3.3.1 Global Paclitaxel Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Paclitaxel Sales Volume, by Type (2020-2031)

3.3.3 Global Paclitaxel Sales Volume, by Type (%) (2020-2031)

3.4 Global Paclitaxel Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Ovarian Cancer

4.1.2 Cervical Cancer

4.1.3 Breast Cancer

4.1.4 Others

4.2 Global Paclitaxel Sales Value by Application

4.2.1 Global Paclitaxel Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Paclitaxel Sales Value, by Application (2020-2031)

4.2.3 Global Paclitaxel Sales Value, by Application (%) (2020-2031)

4.3 Global Paclitaxel Sales Volume by Application

4.3.1 Global Paclitaxel Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Paclitaxel Sales Volume, by Application (2020-2031)

4.3.3 Global Paclitaxel Sales Volume, by Application (%) (2020-2031)

4.4 Global Paclitaxel Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Paclitaxel Sales Value by Region

5.1.1 Global Paclitaxel Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Paclitaxel Sales Value by Region (2020-2025)

5.1.3 Global Paclitaxel Sales Value by Region (2026-2031)

5.1.4 Global Paclitaxel Sales Value by Region (%), (2020-2031)

5.2 Global Paclitaxel Sales Volume by Region

5.2.1 Global Paclitaxel Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Paclitaxel Sales Volume by Region (2020-2025)

5.2.3 Global Paclitaxel Sales Volume by Region (2026-2031)

5.2.4 Global Paclitaxel Sales Volume by Region (%), (2020-2031)

5.3 Global Paclitaxel Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Paclitaxel Sales Value, 2020-2031

5.4.2 North America Paclitaxel Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Paclitaxel Sales Value, 2020-2031

5.5.2 Europe Paclitaxel Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Paclitaxel Sales Value, 2020-2031

5.6.2 Asia Pacific Paclitaxel Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Paclitaxel Sales Value, 2020-2031

5.7.2 South America Paclitaxel Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Paclitaxel Sales Value, 2020-2031

5.8.2 Middle East & Africa Paclitaxel Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Paclitaxel Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Paclitaxel Sales Value

6.2.1 Key Countries/Regions Paclitaxel Sales Value, 2020-2031

6.2.2 Key Countries/Regions Paclitaxel Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Paclitaxel Sales Value, 2020-2031

6.3.2 United States Paclitaxel Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Paclitaxel Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Paclitaxel Sales Value, 2020-2031

6.4.2 Europe Paclitaxel Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Paclitaxel Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Paclitaxel Sales Value, 2020-2031

6.5.2 China Paclitaxel Sales Value by Type (%), 2024 VS 2031

6.5.3 China Paclitaxel Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Paclitaxel Sales Value, 2020-2031

6.6.2 Japan Paclitaxel Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Paclitaxel Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Paclitaxel Sales Value, 2020-2031

6.7.2 South Korea Paclitaxel Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Paclitaxel Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Paclitaxel Sales Value, 2020-2031

6.8.2 Southeast Asia Paclitaxel Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Paclitaxel Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Paclitaxel Sales Value, 2020-2031

6.9.2 India Paclitaxel Sales Value by Type (%), 2024 VS 2031

6.9.3 India Paclitaxel Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Phyton

7.1.1 Phyton Company Information

7.1.2 Phyton Introduction and Business Overview

7.1.3 Phyton Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Phyton Paclitaxel Product Offerings

7.1.5 Phyton Recent Development

7.2 ScinoPharm

7.2.1 ScinoPharm Company Information

7.2.2 ScinoPharm Introduction and Business Overview

7.2.3 ScinoPharm Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 ScinoPharm Paclitaxel Product Offerings

7.2.5 ScinoPharm Recent Development

7.3 Novasep

7.3.1 Novasep Company Information

7.3.2 Novasep Introduction and Business Overview

7.3.3 Novasep Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Novasep Paclitaxel Product Offerings

7.3.5 Novasep Recent Development

7.4 Samyang

7.4.1 Samyang Company Information

7.4.2 Samyang Introduction and Business Overview

7.4.3 Samyang Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Samyang Paclitaxel Product Offerings

7.4.5 Samyang Recent Development

7.5 Polymed

7.5.1 Polymed Company Information

7.5.2 Polymed Introduction and Business Overview

7.5.3 Polymed Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Polymed Paclitaxel Product Offerings

7.5.5 Polymed Recent Development

7.6 TAPI (Teva)

7.6.1 TAPI (Teva) Company Information

7.6.2 TAPI (Teva) Introduction and Business Overview

7.6.3 TAPI (Teva) Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 TAPI (Teva) Paclitaxel Product Offerings

7.6.5 TAPI (Teva) Recent Development

7.7 Fresenius-kabi

7.7.1 Fresenius-kabi Company Information

7.7.2 Fresenius-kabi Introduction and Business Overview

7.7.3 Fresenius-kabi Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Fresenius-kabi Paclitaxel Product Offerings

7.7.5 Fresenius-kabi Recent Development

7.8 Huiang biopharma

7.8.1 Huiang biopharma Company Information

7.8.2 Huiang biopharma Introduction and Business Overview

7.8.3 Huiang biopharma Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 Huiang biopharma Paclitaxel Product Offerings

7.8.5 Huiang biopharma Recent Development

7.9 Southpharma

7.9.1 Southpharma Company Information

7.9.2 Southpharma Introduction and Business Overview

7.9.3 Southpharma Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 Southpharma Paclitaxel Product Offerings

7.9.5 Southpharma Recent Development

7.10 Yunnan Hande

7.10.1 Yunnan Hande Company Information

7.10.2 Yunnan Hande Introduction and Business Overview

7.10.3 Yunnan Hande Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 Yunnan Hande Paclitaxel Product Offerings

7.10.5 Yunnan Hande Recent Development

7.11 Hainan Yew Pharm

7.11.1 Hainan Yew Pharm Company Information

7.11.2 Hainan Yew Pharm Introduction and Business Overview

7.11.3 Hainan Yew Pharm Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)

7.11.4 Hainan Yew Pharm Paclitaxel Product Offerings

7.11.5 Hainan Yew Pharm Recent Development

7.12 Jiangsu Yew Biotechnology

7.12.1 Jiangsu Yew Biotechnology Company Information

7.12.2 Jiangsu Yew Biotechnology Introduction and Business Overview

7.12.3 Jiangsu Yew Biotechnology Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)

7.12.4 Jiangsu Yew Biotechnology Paclitaxel Product Offerings

7.12.5 Jiangsu Yew Biotechnology Recent Development

8 Industry Chain Analysis

8.1 Paclitaxel Industrial Chain

8.2 Paclitaxel Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Paclitaxel Sales Model

8.5.2 Sales Channel

8.5.3 Paclitaxel Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

ScinoPharm

Samyang

Polymed

TAPI (Teva)

Fresenius Kabi

Huiang biopharma

Yunnan Hande

Hainan Yew Pharm

Jiangsu Yew Biotechnology

Southpharma

Novasep

Phyton

List of Tables

Table 1. Paclitaxel Market Trends

Table 2. Paclitaxel Market Drivers & Opportunity

Table 3. Paclitaxel Market Challenges

Table 4. Paclitaxel Market Restraints

Table 5. Global Paclitaxel Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Paclitaxel Revenue Market Share by Company (2020-2025)

Table 7. Global Paclitaxel Sales Volume by Company (2020-2025) & (Kg)

Table 8. Global Paclitaxel Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Paclitaxel Price by Company (2020-2025) & (USD/Kg)

Table 10. Key Manufacturers Paclitaxel Manufacturing Base and Headquarters

Table 11. Key Manufacturers Paclitaxel Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Paclitaxel

Table 13. Global Paclitaxel Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Paclitaxel Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Paclitaxel Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Paclitaxel Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Paclitaxel Sales Market Share in Value by Type (2020-2025)

Table 20. Global Paclitaxel Sales Market Share in Value by Type (2026-2031)

Table 21. Global Paclitaxel Sales Volume by Type: 2020 VS 2024 VS 2031 (Kg)

Table 22. Global Paclitaxel Sales Volume by Type (2020-2025) & (Kg)

Table 23. Global Paclitaxel Sales Volume by Type (2026-2031) & (Kg)

Table 24. Global Paclitaxel Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Paclitaxel Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Paclitaxel Price by Type (2020-2025) & (USD/Kg)

Table 27. Global Paclitaxel Price by Type (2026-2031) & (USD/Kg)

Table 28. Global Paclitaxel Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Paclitaxel Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Paclitaxel Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Paclitaxel Sales Market Share in Value by Application (2020-2025)

Table 32. Global Paclitaxel Sales Market Share in Value by Application (2026-2031)

Table 33. Global Paclitaxel Sales Volume by Application: 2020 VS 2024 VS 2031 (Kg)

Table 34. Global Paclitaxel Sales Volume by Application (2020-2025) & (Kg)

Table 35. Global Paclitaxel Sales Volume by Application (2026-2031) & (Kg)

Table 36. Global Paclitaxel Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Paclitaxel Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Paclitaxel Price by Application (2020-2025) & (USD/Kg)

Table 39. Global Paclitaxel Price by Application (2026-2031) & (USD/Kg)

Table 40. Global Paclitaxel Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Paclitaxel Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Paclitaxel Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Paclitaxel Sales Value by Region (2020-2025) & (%)

Table 44. Global Paclitaxel Sales Value by Region (2026-2031) & (%)

Table 45. Global Paclitaxel Sales Volume by Region (Kg): 2020 VS 2024 VS 2031

Table 46. Global Paclitaxel Sales Volume by Region (2020-2025) & (Kg)

Table 47. Global Paclitaxel Sales Volume by Region (2026-2031) & (Kg)

Table 48. Global Paclitaxel Sales Volume by Region (2020-2025) & (%)

Table 49. Global Paclitaxel Sales Volume by Region (2026-2031) & (%)

Table 50. Global Paclitaxel Average Price by Region (2020-2025) & (USD/Kg)

Table 51. Global Paclitaxel Average Price by Region (2026-2031) & (USD/Kg)

Table 52. Key Countries/Regions Paclitaxel Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Paclitaxel Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Paclitaxel Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Paclitaxel Sales Volume, (2020-2025) & (Kg)

Table 56. Key Countries/Regions Paclitaxel Sales Volume, (2026-2031) & (Kg)

Table 57. Phyton Company Information

Table 58. Phyton Introduction and Business Overview

Table 59. Phyton Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 60. Phyton Paclitaxel Product Offerings

Table 61. Phyton Recent Development

Table 62. ScinoPharm Company Information

Table 63. ScinoPharm Introduction and Business Overview

Table 64. ScinoPharm Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 65. ScinoPharm Paclitaxel Product Offerings

Table 66. ScinoPharm Recent Development

Table 67. Novasep Company Information

Table 68. Novasep Introduction and Business Overview

Table 69. Novasep Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 70. Novasep Paclitaxel Product Offerings

Table 71. Novasep Recent Development

Table 72. Samyang Company Information

Table 73. Samyang Introduction and Business Overview

Table 74. Samyang Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 75. Samyang Paclitaxel Product Offerings

Table 76. Samyang Recent Development

Table 77. Polymed Company Information

Table 78. Polymed Introduction and Business Overview

Table 79. Polymed Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 80. Polymed Paclitaxel Product Offerings

Table 81. Polymed Recent Development

Table 82. TAPI (Teva) Company Information

Table 83. TAPI (Teva) Introduction and Business Overview

Table 84. TAPI (Teva) Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 85. TAPI (Teva) Paclitaxel Product Offerings

Table 86. TAPI (Teva) Recent Development

Table 87. Fresenius-kabi Company Information

Table 88. Fresenius-kabi Introduction and Business Overview

Table 89. Fresenius-kabi Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 90. Fresenius-kabi Paclitaxel Product Offerings

Table 91. Fresenius-kabi Recent Development

Table 92. Huiang biopharma Company Information

Table 93. Huiang biopharma Introduction and Business Overview

Table 94. Huiang biopharma Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 95. Huiang biopharma Paclitaxel Product Offerings

Table 96. Huiang biopharma Recent Development

Table 97. Southpharma Company Information

Table 98. Southpharma Introduction and Business Overview

Table 99. Southpharma Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 100. Southpharma Paclitaxel Product Offerings

Table 101. Southpharma Recent Development

Table 102. Yunnan Hande Company Information

Table 103. Yunnan Hande Introduction and Business Overview

Table 104. Yunnan Hande Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 105. Yunnan Hande Paclitaxel Product Offerings

Table 106. Yunnan Hande Recent Development

Table 107. Hainan Yew Pharm Company Information

Table 108. Hainan Yew Pharm Introduction and Business Overview

Table 109. Hainan Yew Pharm Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 110. Hainan Yew Pharm Paclitaxel Product Offerings

Table 111. Hainan Yew Pharm Recent Development

Table 112. Jiangsu Yew Biotechnology Company Information

Table 113. Jiangsu Yew Biotechnology Introduction and Business Overview

Table 114. Jiangsu Yew Biotechnology Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 115. Jiangsu Yew Biotechnology Paclitaxel Product Offerings

Table 116. Jiangsu Yew Biotechnology Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Paclitaxel Downstream Customers

Table 120. Paclitaxel Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Paclitaxel Product Picture

Figure 2. Global Paclitaxel Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Paclitaxel Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Paclitaxel Sales Volume (2020-2031) & (Kg)

Figure 5. Global Paclitaxel Sales Price (2020-2031) & (USD/Kg)

Figure 6. Paclitaxel Report Years Considered

Figure 7. Global Paclitaxel Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Paclitaxel Players Sales Volume Ranking (2024) & (Kg)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Paclitaxel Revenue in 2024

Figure 10. Paclitaxel Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Natural Paclitaxel API Picture

Figure 12. Semi-synthetic Paclitaxel API Picture

Figure 13. Global Paclitaxel Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Paclitaxel Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Paclitaxel Sales Volume by Type (2020 VS 2024 VS 2031) & (Kg)

Figure 16. Global Paclitaxel Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Paclitaxel Price by Type (2020-2031) & (USD/Kg)

Figure 18. Product Picture of Ovarian Cancer

Figure 19. Product Picture of Cervical Cancer

Figure 20. Product Picture of Breast Cancer

Figure 21. Product Picture of Others

Figure 22. Global Paclitaxel Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 23. Global Paclitaxel Sales Value Market Share by Application, 2024 & 2031

Figure 24. Global Paclitaxel Sales Volume by Application (2020 VS 2024 VS 2031) & (Kg)

Figure 25. Global Paclitaxel Sales Volume Market Share by Application, 2024 & 2031

Figure 26. Global Paclitaxel Price by Application (2020-2031) & (USD/Kg)

Figure 27. North America Paclitaxel Sales Value (2020-2031) & (US$ Million)

Figure 28. North America Paclitaxel Sales Value by Country (%), 2024 VS 2031

Figure 29. Europe Paclitaxel Sales Value, (2020-2031) & (US$ Million)

Figure 30. Europe Paclitaxel Sales Value by Country (%), 2024 VS 2031

Figure 31. Asia Pacific Paclitaxel Sales Value, (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Paclitaxel Sales Value by Region (%), 2024 VS 2031

Figure 33. South America Paclitaxel Sales Value, (2020-2031) & (US$ Million)

Figure 34. South America Paclitaxel Sales Value by Country (%), 2024 VS 2031

Figure 35. Middle East & Africa Paclitaxel Sales Value, (2020-2031) & (US$ Million)

Figure 36. Middle East & Africa Paclitaxel Sales Value by Country (%), 2024 VS 2031

Figure 37. Key Countries/Regions Paclitaxel Sales Value (%), (2020-2031)

Figure 38. Key Countries/Regions Paclitaxel Sales Volume (%), (2020-2031)

Figure 39. United States Paclitaxel Sales Value, (2020-2031) & (US$ Million)

Figure 40. United States Paclitaxel Sales Value by Type (%), 2024 VS 2031

Figure 41. United States Paclitaxel Sales Value by Application (%), 2024 VS 2031

Figure 42. Europe Paclitaxel Sales Value, (2020-2031) & (US$ Million)

Figure 43. Europe Paclitaxel Sales Value by Type (%), 2024 VS 2031

Figure 44. Europe Paclitaxel Sales Value by Application (%), 2024 VS 2031

Figure 45. China Paclitaxel Sales Value, (2020-2031) & (US$ Million)

Figure 46. China Paclitaxel Sales Value by Type (%), 2024 VS 2031

Figure 47. China Paclitaxel Sales Value by Application (%), 2024 VS 2031

Figure 48. Japan Paclitaxel Sales Value, (2020-2031) & (US$ Million)

Figure 49. Japan Paclitaxel Sales Value by Type (%), 2024 VS 2031

Figure 50. Japan Paclitaxel Sales Value by Application (%), 2024 VS 2031

Figure 51. South Korea Paclitaxel Sales Value, (2020-2031) & (US$ Million)

Figure 52. South Korea Paclitaxel Sales Value by Type (%), 2024 VS 2031

Figure 53. South Korea Paclitaxel Sales Value by Application (%), 2024 VS 2031

Figure 54. Southeast Asia Paclitaxel Sales Value, (2020-2031) & (US$ Million)

Figure 55. Southeast Asia Paclitaxel Sales Value by Type (%), 2024 VS 2031

Figure 56. Southeast Asia Paclitaxel Sales Value by Application (%), 2024 VS 2031

Figure 57. India Paclitaxel Sales Value, (2020-2031) & (US$ Million)

Figure 58. India Paclitaxel Sales Value by Type (%), 2024 VS 2031

Figure 59. India Paclitaxel Sales Value by Application (%), 2024 VS 2031

Figure 60. Paclitaxel Industrial Chain

Figure 61. Paclitaxel Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Paclitaxel API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Taxol Market Research Report 2024

Global Natural Paclitaxel Market Research Report 2024

Global Camptothecin Market Insights Forecast to 2030

Global Paclitaxel and Docetaxel APIs Market Research Report 2024

Global Taxane Antineoplastic Drug Market Research Report 2024

Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Research Report 2024

Global Bulk Paclitaxel Market Research Report 2025

Global Paclitaxel and Docetaxel Market Research Report 2024

Global Paclitaxel eluting Stent Market Insights Forecast to 2030

Liposomal Paclitaxel Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Protein Bound Paclitaxel Market Research Report 2024

Global Albumin bound Paclitaxel Market Research Report 2024

Cabazitaxel API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Protein bound Paclitaxel Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Paclitaxel Coated Balloon Catheter Market Research Report 2024

Global Paclitaxel Micelles Market Research Report 2024

Global Breast Cancer Treatment Drugs Market Insights Forecast to 2030

Global Mitotic Inhibitors Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions